First Manhattan CO Novo Nordisk A S Transaction History

First Manhattan CO

$32.4 Billion
Q1 2025

A detailed history of First Manhattan CO transactions in Novo Nordisk A S stock. As of the latest transaction made, First Manhattan CO holds 7,241 shares of NVO stock, worth $487,681. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,241

Previous 7,466 3.01%

Holding current value

$487,681

Previous $642,000 21.81%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$69.3 - $90.95 $15,592 - $20,463	-225 Reduced 3.01%	7,241 $502,000
Q4 2024 Feb 14, 2025	BUY	$85.0 - $120.04 $20,655 - $29,169	243 Added 3.36%	7,466 $642,000
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $1,905 - $2,326	16 Added 0.22%	7,223 $860,000
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $29,082 - $34,817	237 Added 3.4%	7,207 $1.03 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $9,802 - $13,048	96 Added 1.4%	6,970 $894,000
Q4 2023 Feb 13, 2024	BUY	$87.78 - $105.45 $170,995 - $205,416	1,948 Added 39.55%	6,874 $711,000
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $223,985 - $491,467	2,463 Added 100.0%	4,926 $447,000
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $27,129 - $32,623	-205 Reduced 7.68%	2,463 $391,000
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $49,121 - $64,823	479 Added 21.88%	2,668 $361,000
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $27,996 - $34,187	-292 Reduced 11.77%	2,189 $245,000
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $1,097 - $1,386	13 Added 0.53%	2,481 $238,000
Q1 2021 May 14, 2021	BUY	$67.06 - $75.82 $51,569 - $58,305	769 Added 45.26%	2,468 $166,000
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $958 - $1,107	-15 Reduced 0.88%	1,699 $118,000
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $401,247 - $442,386	-6,300 Reduced 78.61%	1,714 $119,000
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $5,034 - $5,842	-86 Reduced 1.06%	8,014 $524,000
Q3 2019 Nov 13, 2019	SELL	$47.54 - $53.43 $831,950 - $935,025	-17,500 Reduced 68.36%	8,100 $418,000
Q2 2018 Aug 01, 2018	SELL	$44.29 - $50.42 $26,574 - $30,252	-600 Reduced 2.29%	25,600 $1.18 Million
Q4 2017 Jan 22, 2018	SELL	$47.53 - $53.73 $7,699 - $8,704	-162 Reduced 0.61%	26,200 $1.41 Million
Q3 2017 Oct 25, 2017	BUY	$41.15 - $49.22 $1.08 Million - $1.3 Million	26,362	26,362 $1.27 Million

Others Institutions Holding NVO

# of Institutions

1,768

Shares Held

330M

Call Options Held

11.3M

Put Options Held

15.5M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $152B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Account

First Manhattan CO Novo Nordisk A S Transaction History